Home » Reports » Stock Report » Market Risers: Advanced Oncotherapy PLC, Ashtead Group plc, AstraZeneca plc, Direct Line Insurance Group PLC
Advanced Oncotherapy plc

Market Risers: Advanced Oncotherapy PLC, Ashtead Group plc, AstraZeneca plc, Direct Line Insurance Group PLC

Shares in Advanced Oncotherapy PLC ticker lookup code: LON:AVO has gained 7.64% or 2.02 points throughout today’s trading session so far. Investors are a positive bunch during the trading session. Range high for the period so far is 28.52 dipping to 26.25. Volume total for shares traded at this point reached 77,783 whilst the average number of shares exchanged is 272,253. The 52 week high for the shares is 209.88 about 183.38 points different to the previous business close and a 52 week low sitting at 23.88 is a variance of 2.62 points. Advanced Oncotherapy PLC now has a 20 SMA of 30.33 and now its 50 day simple moving average now of 42.86. The current market capitalisation is £21.36m at the time of this report. Share price is traded in GBX. Mcap is measured in GBP. This article was written with the last trade for Advanced Oncotherapy PLC being recorded at Tuesday, April 25, 2017 at 12:29:44 PM GMT with the stock price trading at 28.52 GBX.

 

 

Shares of Ashtead Group plc EPIC code: LON:AHT has risen 1.78% or 29 points during today’s session so far. Investors are a positive bunch during the trading session. The period high has peaked at 1658 and hitting a low of 1627.68. The total volume of shares exchanged so far has reached 342,508 whilst the daily average number of shares exchanged is just 1,588,325. The 52 week high for the share price is 1764 equating to 139 points difference from the previous days close and the 52 week low at 859 is a variance of 766 points. Ashtead Group plc now has a 20 simple moving average of 1665.9 and now its 50 day moving average now at 1689.37. This puts the market cap at £8,257.19m at the time of this report. The stock is traded in GBX. Mcap is measured in GBP. This article was written with the last trade for Ashtead Group plc being recorded at Tuesday, April 25, 2017 at 12:36:20 PM GMT with the stock price trading at 1654 GBX.

 

 

The trading price for AstraZeneca plc company symbol: LON:AZN has stepped up 1.14% or 53 points during today’s session so far. Buyers have remained optimistic throughout the session. The period high was 4783.29 dipping to 4634. The total volume of shares traded by this point was 924,148 whilst the average number of shares exchanged is 2,120,029. A 52 week high for the stock is 5505 some 842.5 points difference from the previous days close and putting the 52 week low at 3680 making a difference of 982.5 points. AstraZeneca plc has a 20 SMA of 4864.47 and also a 50 day moving average now of 4836.02. The current market capitalisation is £59,661.12m at the time of this report. The currency for this stock is Great British pence.Market cap is measured in GBP. This article was written with the last trade for AstraZeneca plc being recorded at Tuesday, April 25, 2017 at 12:36:20 PM GMT with the stock price trading at 4715.5 GBX.

 

 

Shares in Direct Line Insurance Group PLC EPIC code: LON:DLG has climbed 1.02% or 3.5 points throughout the session so far. Market buyers have remained positive throughout the trading session. Range high for the period has seen 350.05 dipping to 343.95. The total volume of shares exchanged through this period comes to 1,729,319 with the daily average traded share volume around 5,787,779. The 52 week high for the share price is 400.7 equating to 56.6 points difference from the previous close and the 52 week low at 323 a difference of some 21.1 points. Direct Line Insurance Group PLC has a 20 day moving average of 346.06 and also a 50 day SMA of 348.29. The current market cap is £4,779.50m at the time of this report. The currency for this stock is GBX. Market cap is measured in GBP. This article was written with the last trade for Direct Line Insurance Group PLC being recorded at Tuesday, April 25, 2017 at 12:35:48 PM GMT with the stock price trading at 347.6 GBX.

Join us on our new LinkedIn page

Follow us on LinkedIn